MARKET

EKSO

EKSO

Ekso Bionics
NASDAQ

Real-time Quotes | Nasdaq Last Sale

6.32
-0.72
-10.23%
After Hours: 6.32 0 0.00% 19:15 04/13 EDT
OPEN
6.82
PREV CLOSE
7.04
HIGH
6.90
LOW
6.20
VOLUME
486.70K
TURNOVER
--
52 WEEK HIGH
14.98
52 WEEK LOW
2.670
MARKET CAP
79.63M
P/E (TTM)
-2.5278
1D
5D
1M
3M
1Y
5Y
Worldwide Artificial Organ and Bionics Industry to 2025 - Advantageous in Comparison Prosthetics Presents Opportunities
, /PRNewswire/ -- The report has been added to offering.
PR Newswire - PRF · 11h ago
Southeast Asia Industrial and Service Robot Market Trends, Share, Size, Growth, Supply and Manufacturers Analysis Research Report 2025
Japan, Japan, Tue, 13 Apr 2021 07:53:00 / Comserve Inc. / -- The report analyze market size, share, growth, trends, segmentation, top key players,...
Comserve · 17h ago
Gait Trainer Market PESTEL Analysis, SWOT Analysis, CAGR and Value Chain Study Forecast to 2031
Apr 13, 2021 (WiredRelease via Comtex) -- Market.us adopted a multidisciplinary detain during the pandemic-era to focus on the revolutionary trends, growth...
marketresearch.biz · 20h ago
Medical Robotic Systems Market 2021 Global Technology, Development, Industry Share, Size, Growth, Trends and COVID-19 Impact Analysis 2027
Apr 12, 2021 (Heraldkeepers) -- The Global Medical Robotic System Market is expected to exceed more than US$ 6.50 Billion by 2024 at a CAGR of 14.5% in the...
Heraldkeepers · 1d ago
Medical Robots Market Research Report by Device, by Service, by Industry – Global Forecast to 2025 – Cumulative Impact of COVID-19
Heraldkeepers · 1d ago
Ekso Bionics (EKSO) Surges 9.4%: Is This an Indication of Further Gains?
Ekso Bionics (EKSO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Zacks · 1d ago
Socially Assistive Healthcare Assistive Robot Market Analysis By Business Share, Development Trends, Segmentation, Opportunities and Forecast to 2025
Apr 12, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." Global "Socially Assistive Healthcare...
The Express Wire · 1d ago
Human Enhancement Market 2021 Demand, Growth, Opportunities and Forecast 2023 Research Report with Share, Size
Apr 12, 2021 (The Expresswire) -- Human Enhancement Market 2021 report tells about the production process, raw materials and equipment suppliers, various...
The Express Wire · 1d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of EKSO. Analyze the recent business situations of Ekso Bionics through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average EKSO stock price target is 10.00 with a high estimate of 11.00 and a low estimate of 9.00.
EPS
Institutional Holdings
Institutions: 72
Institutional Holdings: 4.50M
% Owned: 35.74%
Shares Outstanding: 12.60M
TypeInstitutionsShares
Increased
9
246.64K
New
12
84.05K
Decreased
2
23.12K
Sold Out
1
143
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+1.67%
Healthcare Equipment & Supplies
+1.78%
Key Executives
Chairman/Executive Director
Steven Sherman
President/Chief Executive Officer/Director
Jack Peurach
Chief Financial Officer
John Glenn
Managing Director
Matthias Stief
Vice President
Jason Jones
Other
Bill Shaw
Other
William Shaw
Director
Mary Cloyd
Director
Rhonda Wallen
Independent Director
Marilyn Hamilton
Director
Ted Wang
Independent Director
Dan Boren
Independent Director
Charles Li
Independent Director
Thomas Schreck
Independent Director
Stanley Stern
No Data
  • All
  • Financials
  • Insiders
More
About EKSO
Ekso Bionics Holdings, Inc., formerly PN Med Group, Inc., designs, develops and sells wearable bionic human exoskeletons that have applications in healthcare, industrial, military and consumer markets. The Company operates through two segments: Engineering Services and Medical. The Engineering Services segment is engaged in collaborative research and development service arrangements, technology license agreements and government grants where it uses its robotics domain knowledge in bionic exoskeletons to bid on and procure contracts and grants from entities, such as the National Science Foundation and the Defense Advanced Research Projects Agency. The Medical segment designs, engineers and manufactures exoskeletons for applications in the medical and military markets. The Company's exoskeleton systems are worn over the user's clothing. The exoskeleton systems serve various markets, which can be used both by able-bodied users, as well as by persons with physical disabilities.

Webull offers kinds of Ekso Bionics Holdings Inc stock information, including NASDAQ:EKSO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EKSO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading EKSO stock methods without spending real money on the virtual paper trading platform.